Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Extended-release oxycodone
(D05312)		1件: Oxycodone1件: Oxycodone (D05312) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2Oxycodone
(D05312)		1件: Oxycodone1件: Oxycodone (D05312) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 13, 70, 226, 298 💬
3Oxycodone Depot ”Sandoz”, depot tablets
(D05312)		1件: Oxycodone1件: Oxycodone (D05312) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 298 💬
4OXYCODONE HYDROCHLORIDE
(D05312)		1件: Oxycodone1件: Oxycodone (D05312) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬4件: 6, 70, 226, 298 💬
5Oxycodone naloxone prolonged release tablets
(D05312)		2件: Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
6Oxycodone Orion
(D05312)		1件: Oxycodone1件: Oxycodone (D05312) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 70 💬
7Oxycodone/naloxone prolonged release t
(D05312)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
8Oxycodone/Naloxone Prolonged Release tablets
(D05312)		2件: Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
9Oxycodone/naloxone prolonged release tablets 10 mg /5 mg
(D05312)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
10Oxycodone/naloxone prolonged release tablets 10/5 mg
(D05312)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
11Oxycodone/naloxone prolonged release tablets 20 mg /10 mg
(D05312)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
12Oxycodone/naloxone prolonged release tablets 20/10 mg
(D05312)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
13Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg
(D05312)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
14Oxycodone/naloxone prolonged release tablets 5/2.5 mg
(D05312)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone (D05312),
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
15PR Oxycodone
(D05312)		1件: Oxycodone1件: Oxycodone (D05312) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬